Business
Press Release Jun 21 2024
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 21, 2024, titled "Sun Pharma signs non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 21, 2024, titled \"Sun Pharma signs non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India\". View Attachment","length":465,"tagName":"div"}]